Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
Condition: Heart Failure Interventions: Drug: LCZ 696; Drug: Icatibant; Drug: placebo; Drug: Para-aminohippurate; Drug: Iohexol Sponsor: Vanderbilt University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials